Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e441-e444. doi: 10.1016/j.clml.2018.07.289. Epub 2018 Aug 27.
No abstract available

Keywords: BCL-2 inhibitor; Efficacy; Feasibility; Safety; Salvage therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / administration & dosage
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
  • Drug Resistance, Neoplasm / drug effects*
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Prognosis
  • Salvage Therapy*
  • Sulfonamides / administration & dosage
  • Young Adult

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Asparaginase
  • venetoclax